CRISPR

CRISPR1-grb2b

ID
ZDB-CRISPR-220408-4
Name
CRISPR1-grb2b
Previous Names
None
Target
Sequence
5' - GATGAGCTGAGTTTTAAACG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
mu404 grb2b
Expression
Gene expression in Wild Types + CRISPR1-grb2b
No data available
Phenotype
Phenotype resulting from CRISPR1-grb2b
No data available
Phenotype of all Fish created by or utilizing CRISPR1-grb2b
Phenotype Fish Conditions Figures
thoracic duct absent, abnormal grb2bmu404/mu404 standard conditions Fig. 3 with image from Mauri et al., 2021
trunk vascular lymphangioblast absent, abnormal grb2bmu404/mu404 standard conditions Fig. 3 with image from Mauri et al., 2021
horizontal myoseptum vascular lymphangioblast decreased amount, abnormal grb2bhu6987/+; grb2bmu404/+; hu5333Tg; hu7135Tg standard conditions Fig. 1 with image from Mauri et al., 2021
intersegmental artery decreased amount, abnormal grb2bmu404/+; hu5333Tg; hu7135Tg standard conditions Fig. 8 with image from Mauri et al., 2021
intersegmental vein increased amount, abnormal grb2bmu404/+; hu5333Tg; hu7135Tg standard conditions Fig. 8 with image from Mauri et al., 2021
vascular lymphangioblast decreased amount, abnormal grb2bmu404/+; hu5333Tg; hu7135Tg standard conditions Fig. 4 with image from Mauri et al., 2021
posterior cardinal vein blood vessel endothelial cell migration decreased occurrence, abnormal grb2bmu404/mu404; hu5333Tg; hu7135Tg standard conditions Fig. 6 with image from Mauri et al., 2021
intersegmental vein decreased amount, abnormal grb2bmu404/mu404; hu5333Tg; hu7135Tg standard conditions Fig. 8 with image from Mauri et al., 2021
posterior cardinal vein sprouting angiogenesis disrupted, abnormal grb2bmu404/mu404; hu5333Tg; hu7135Tg standard conditions Fig. 6 with image from Mauri et al., 2021
intersegmental artery increased amount, abnormal grb2bmu404/mu404; hu5333Tg; hu7135Tg standard conditions Fig. 8 with image from Mauri et al., 2021
posterior cardinal vein blood vessel endothelial cell ab9-mapk labeling decreased amount, abnormal grb2bmu404/mu404; hu7135Tg standard conditions Fig. 5 with image from Mauri et al., 2021
posterior cardinal vein blood vessel endothelial cell ab5-prox1 labeling decreased amount, abnormal grb2bmu404/mu404; hu7135Tg standard conditions Fig. 5 with image from Mauri et al., 2021
trunk vascular lymphangioblast absent, abnormal grb2amu405/+; grb2bmu404/mu404 standard conditions Fig. 3 with image from Mauri et al., 2021
thoracic duct absent, abnormal grb2amu405/+; grb2bmu404/mu404 standard conditions Fig. 3 with image from Mauri et al., 2021
trunk vascular lymphangioblast absent, abnormal grb2amu405/mu405; grb2bmu404/mu404 standard conditions Fig. 3 with image from Mauri et al., 2021
horizontal myoseptum vascular lymphangioblast decreased amount, exacerbated grb2bmu404/+; hu5333Tg; hu7135Tg + MO3-flt4 standard conditions Fig. 4 with image from Mauri et al., 2021
Citations